Ganfort Unit Dose
Ganfort Unit Dose is a medicine authorised by Swissmedic under authorisation number 65063. The authorisation holder is AbbVie AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 20 March 2014 and the authorisation is valid without a time limit. ATC code S01ED51 places the medicine in the group Ophthalmologicals.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ganfort Unit Dose, Augentropfen | B | 20 March 2014 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 x 0.4 | ml | S01ED51 | 11.09.0. | B |
| 2 | 90 x 0.4 | ml | S01ED51 | 11.09.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ganfort Unit Dose authorised in Switzerland?
Yes. Ganfort Unit Dose is authorised by Swissmedic under authorisation number 65063, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ganfort Unit Dose have?
Ganfort Unit Dose is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ganfort Unit Dose?
The authorisation holder is AbbVie AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.